Skip to main content
Log in

Associations among maternal soy intake, isoflavone levels in urine and blood samples, and maternal and umbilical hormone concentrations (Japan)

  • Original Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Absract

Objectives

In utero exposure to high levels of endogenous estrogens has been hypothesized to increase breast cancer risk in later life. A high intake of soy has been suggested to protect against breast cancer. We examined the hypothesis that maternal soy intake may be inversely associated with pregnancy hormone levels.

Methods

The concentrations of hormones (estradiol, estriol, and testosterone) and isoflavones (genistein, deidzein, and equol) were measured in the maternal urine and serum, and umbilical cord blood of 194 women during pregnancy and at delivery. Soy intake during pregnancy was assessed by 5-day diet records at approximately the 29th week of pregnancy.

Results

High correlations were observed for isoflavone levels between maternal samples and umbilical cord blood, indicating that isoflavone can be transferred from the maternal to the fetal compartment. None of the hormones measured in umbilical cord blood was significantly associated with any of the isoflavones measured. There were a few significant associations between maternal hormone levels and isoflavone measures during pregnancy, but their patterns of associations varied by gestational week and differed depending on whether isoflavone exposure was measured by diet records, urine or serum.

Conclusion

Our data contain no strong evidence showing that soy intake affects hormone levels during pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Trichopoulos D (1990) Hypothesis: does breast cancer originate in utero. Lancet 335:939–940

    Article  PubMed  CAS  Google Scholar 

  2. Hsieh CC, Tzonou A, Trichopoulos D (1991) Birth order and breast cancer risk. Cancer Cause Control 2:95–98

    Article  CAS  Google Scholar 

  3. Michels KB, Trichopoulos D, Robins JM, et al (1996) Birthweight as a risk factor for breast cancer. Lancet 48:1542–1546

    Article  Google Scholar 

  4. Knopp RH, Bergelin RO, Wahl PW, Walden CE (1985) Relationships of infant birth size to maternal lipoproteins, apoproteins, fuels, hormones, clinical chemistries, and body weight at 36 weeks gestation. Diabetes 34:71–77

    PubMed  Google Scholar 

  5. Kaijser M, Granath F, Jacobsen G, Cnattingius S, Ekbom A (2000) Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometrics data. Epidemiology 11:315–319

    Article  PubMed  CAS  Google Scholar 

  6. Mucci LA, Lagiou P, Tamimi RM, Hsieh C-C, Adami H-O, Trichopoulos D (2003) Pregnancy estriol, estradiol, progesterone and prolactin in relation to birth weight and other birth size variables (United States). Cancer Cause Control 14:311–318

    Article  Google Scholar 

  7. Peck JD, Hulka BS, Savitz DA, Baird D, Poole C, Richardson BE (2003) Accuracy of fetal growth indicators as surrogate measures of steroid hormone levels during pregnancy. Am J Epidemiol 157:258–266

    Article  PubMed  Google Scholar 

  8. Willett WC (2001) Diet and breast cancer. J Intern Med 249:395–411

    Article  PubMed  CAS  Google Scholar 

  9. Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S (2003) Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst 95:906–913

    Article  PubMed  CAS  Google Scholar 

  10. Grace PB, Taylor JI, Low Y-L, et al (2004) Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European Prospective Investigation of Cancer and Nutrition-Norfolk. Cancer Epidemiol Biomarkers Prev 13:698–708

    PubMed  CAS  Google Scholar 

  11. Pike AC, Brzozowski AM, Hubbard RE, et al (1999) Structure of the ligand-binding domain of estrogen receptor beta in the presence of a partial against and a full antagonist. EMBO J 18:4608–4618

    Article  PubMed  CAS  Google Scholar 

  12. Adlercreutz H, Yamada T, Wähälä K, Watanabe S (1999) Maternal and neonatal phytoestrogens in Japanese women during birth. Am J Obstet Gynecol 180:737–743

    Article  PubMed  CAS  Google Scholar 

  13. Le Bail J-C, Champavier Y, Chulia A-J, Habrioux G (2000) Effects of phytoestrogens on aromatase, 3β and 17β-hydroxysteroid dehydrogenanase activities and human breast cancer cells. Life Sci 66:1281–1291

    Article  PubMed  CAS  Google Scholar 

  14. Lu L-JW, Anderson KE, Grady JJ, Nagamani M (1996) Effects of soya consumption for one month on steroid hormones in premenopausal women:implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev 5:63–70

    PubMed  CAS  Google Scholar 

  15. Nagata C, Takatsuka N, Inaba S, Kawakami N, Shimizu H (1998) Effect of soymilk consumption on serum esrogen concentrations in premenopausal Japanese women. J Natl Cancer Inst 90:1830–1835

    Article  PubMed  CAS  Google Scholar 

  16. Wu AH, Stanczyk FZ, Hendrich S, et al (2000) Effects of soy foods on ovarian function in premenopausal women. Br J Cancer 82:1879–1886

    Article  PubMed  CAS  Google Scholar 

  17. Cassidy A, Bingham S, Setchell KDR (1994) Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 60:333–340

    PubMed  CAS  Google Scholar 

  18. Duncan AM, Merz BE, Xu X, Negel TC, Phipps WR, Kurzer MS (1999) Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab 84:192–197

    Google Scholar 

  19. Shimizu H, Ohwaki A, Kurisu Y, et al (1999) Validity and reproducibility of a quantitative food frequency questionnaire for a cohort study in Japan. Jpn J Clin Oncol 29:38–44

    Article  PubMed  CAS  Google Scholar 

  20. Nagata C, Takatsuka N, Kawakami N, Shimizu H (2001) Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. Am J Epidemiol 153:790–793

    Article  PubMed  CAS  Google Scholar 

  21. Coward L, Kirk M, Albin N, Barnes S (1996) Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clin Chim Acta 247:121–142

    Article  PubMed  CAS  Google Scholar 

  22. Lundh TJ, Pettersson H, Kiessling KH (1988) Liquid chromatographic determination of estrogens daidzein, formononetin, coumestrol, and equol in bovine blood plasma and urine. J Assoc Off Anal Chem 7:938–941

    Google Scholar 

  23. Willett W (1990) Implication of total energy intake for epidemiological analyses. In: Willett W (ed) Nutritional epidemiology. Oxford University Press, Oxford, pp 245–271

    Google Scholar 

  24. Harrison RM, Phillippi PP, Swan K, Henson MC (1999) Effect of genistein on steroid hormone production in the pregnant rhesus monkey. OSEBM 222:78–84

    CAS  Google Scholar 

  25. Steele VE, Pereira MA, Sigman CC, Keloff GJ (1995) Cancer chemopreventive agent development strategies for genistein. J Nutr 125:713S–716S

    PubMed  CAS  Google Scholar 

  26. Hilakivi-Clarke L, Cho E, Cabanes A, et al (2002) Dietary modulation of pregnancy estrogen levels and breast cancer risk among female rat offspring. Clin Cancer Res 8:3601–3610

    PubMed  CAS  Google Scholar 

  27. Awoniyi CA, Roberts D, Veeramachaneni DNR, Hurst BS, Tucker KE, Sclaff WD (1998) Reproductive sequelae in female rats after in utero and neonatal exposure to the phytoestrogen genistein. Fertil Steril 70:440–447

    Article  PubMed  CAS  Google Scholar 

  28. Takagi H, Shibutani M, Lee K-Y, et al (2004) Lack of modyfying effects of genistein on disruption of the reproductive system by perinatal dietary exposure to ethinylestradiol in rats. Reprod Toxicol 18:687–700

    Article  PubMed  CAS  Google Scholar 

  29. Nagata C, Kabuto M, Kurisu Y, Shimizu H (1997) Decreased serum estradiol concentration associated with high dietary intake of soy products in premenopausal Japanese women. Nutr Cancer 29:228–233

    Article  PubMed  CAS  Google Scholar 

  30. Nagata C, Takatsuka N, Kawakami N, Shimizu H (2000) Total and monounsaturated fat intake and serum estrogen concentrations in premenopausal Japanese women. Nutr Cancer 38:37–39

    Article  PubMed  CAS  Google Scholar 

  31. Yamamoto S, Sobue T, Sasaki S, et al (2001) Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr 131:2741–2747

    PubMed  CAS  Google Scholar 

  32. Lampe JW, Karr SC, Hutcins AM, Slavin J (1998) Urinary equol excretion with a soy challenge: influence of habitual diet. PSEBM 217:335–339

    CAS  Google Scholar 

  33. Morito K, Hirose T, Kinjo J, et al (2001) Interaction of phytoestrogens with estrogen receptor α and β. Biol Pharm Bull 24:351–356

    Article  PubMed  CAS  Google Scholar 

  34. Duncan AM, Merz-Demlow BE, Xu X, Phipps WR, Kurzer M (2000) Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev 9:581–586

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Supported by grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chisato Nagata.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagata, C., Iwasa, S., Shiraki, M. et al. Associations among maternal soy intake, isoflavone levels in urine and blood samples, and maternal and umbilical hormone concentrations (Japan). Cancer Causes Control 17, 1107–1113 (2006). https://doi.org/10.1007/s10552-006-0044-4

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-006-0044-4

Keywords

Navigation